Myocardial perfusion defects in patients with autoimmune diseases: A prospective study. Analysis of two diagnostic tests

Lupus

Volumn 15, Issue 1, 2006, Pages 38-43

  Espinola Zavaleta, N ^a   Alexanderson Rosas, E ^a   Granados, N ^a   Soto, M Elena ^a   Amigo, M C ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Autoimmune disease; Contrast echocardiography; Sestamibi single photon emission computed tomography

Indexed keywords

DOBUTAMINE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MALE; MYOCARDIAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCINTIGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CORONARY ARTERIOSCLEROSIS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33144469998     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2259oa     Document Type: Article

References (33)

1. Ghaffari Sasan MD. Detection and management of coronary artery disease in patients with rheumatologic disorders. Rheumatic Dis Clin N Am 1999; 25(3): 657-668.
2. French WJ. Trends in acute myocardial infarction management: use of the national registry of myocardial infarction in quality improvement. Am J Cardiol 2000; 85: 5B-9B.
3. Rabbani R, Topol E. Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res 1999; 41: 402-417.
4. Hamm C, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118-122.
5. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
6. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999; 340(2): 115-125.
7. George J, Afek A, Gilburd B, Harats D, Shoenfeld Y. Autoinmunity in atherosclerosis: lessons from experimental models. Lupus 2000; 9: 223-227.
8. De Winther M, Hofker M. Scavenging new insights into atherogenesis. J Clin Invest 2000; 105(8): 1039-1041.
9. Wierzbicki AS. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Lupus 2000; 9: 194-201.
10. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14(S13): 223-226.
11. Petri M, Pérez-Gutthann S, Spence D, Hochberg MC. Risk factor for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
12. Sultan H, Berson J, Mirotznik J, Ginzler EM. Lack of evidence for corticosteroids as a risk factor for coronary artery disease in systemic lupus erythematosus. In Northeast Region American College of Rheumatology Meeting, New York, June 1994.
13. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 408-415.
14. Badui E, García-Rubi D, Robles E et al. Cardiovascular manifestations in systemic lupus erythematosus; prospective study of 100 patients. Angiology 1985; 36: 431-441.
15. Hosenpud JD, Montanaro A, Hart MV et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984; 77: 286-292.
16. Ginzler E, Stein R, Solomon N, Frank F. Coronary artery disease and ventricular function in long-term systemic lupus erythematosus patients. In American Rheumatism Association Meeting, Atlanta, May 1980.
17. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. High prevalence of myocardial perfusion abnormalities in women with systemic lupus erythematosus. Arthritis Rheum 1997; 40: S219.
18. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 2000; 27: 2372-2377.
19. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 Criteria. Arthritis Rheum 1988; 31: 315-328.
20. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
21. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42(7): 1309-1311.
22. Rainbird A, Mulvagh S, Oh K, McCully R, Klarich K. Contrast dobutamine stress echocardiography: Clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 2001; 14: 378-385.
23. Main ML, Grayburn P. Clinical applications of transpulmonary contrast echocardiography. Am Heart J 1999; 137: 144-153.
24. Porter TR, Xie F, Li S, D'Sa A, Rafter P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J Am Soc Echocardiogr 1996; 9: 599-605.
25. Porter TR, Xie F, Kricsfeld D, Ambrusterbe RW. Improved myocardial contrast with second harmonic transient response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 1996; 27: 1496-501.
26. Crouse L, Kramer P. Stress echocardiography: Technical considerations. Prog Cardiovasc Dis 2001; 43(4): 303-314.
27. Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74: 275-284.
28. Manzi S, Wasko M-C. Inflamamation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000; 59: 321-325.
29. Cisternas M, Gutierrrez MA, Klaassen J, Acosta AM, Jacobelli S. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 2002; 29: 1619-1622.
30. Mutru O, Laakso M, Isomaki H, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989; 76: 71-77.
31. Bruce IN, Gladman DD, Ibañez D, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. J Rheumatol 2003; 30: 288-291.
32. Lin JJ, Hsu HB, Sun SS et al. Single photon emission computed tomography of technetium-99 m tetrofosmin myocardial perfusion imaging in patients with systemic lupus erythematosus - a preliminary report. Jpn Heart J 2003; 44: 83-89.
33. Schillaci O, Lagana B, Danieli R et al. Technetium-99 m Sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 713-717.